Dana-Farber’s Breast Oncology Center shared a post on X:
“Check out this recent Annals of Oncology ctDNA review and meta-analysis”
Title: Circulating tumor DNA clearance as a predictive biomarker of pathologic complete response in patients with solid tumors treated with neoadjuvant immune checkpoint inhibitors: a systematic review and meta-analysis.
Authors: Carmine Valenza, E.F. Saldanha, Y. Gong, Pietro De Placido, David Gritsch, H. Ortiz, Dario Trapani, F. Conforti, C. Cremolini, S. Peters, J. Mateo, V. Subbiah, Heather Parsons, Ann Partridge, Giuseppe Curigliano
You can read the Full Article on ESMO Annals of Oncology.
More posts featuring Dana-Farber’s Breast Oncology Center.